Method and medicament for inhibiting the expression of a given gene
View Patent ↗The invention relates to an isolated RNA that mediates RNA interference of an mRNA to which it corresponds and a method of mediating RNA interference of mRNA of a gene in a cell or organism using the isolated RNA.
1. An isolated double stranded RNA (dsRNA) comprising two separate complementary oligoribonucleotide strands,
wherein each of said strands consists of 21 nucleotides in length,
wherein the dsRNA does not comprise a full length RNA transcript of a mammalian target gene,
wherein one strand of said dsRNA is complementary to less than the full length of an RNA transcript of said mammalian target gene,
wherein said separate oligoribonucleotide strands are chemically linked to reduce dissociation as compared to non-linked oligoribonucleotide strands,
and wherein said dsRNA is capable of specifically inhibiting the expression of said mammalian target gene.
2. The dsRNA of claim 1 , wherein at least one of said oligoribonucleotide strands comprises at least one chemically modified nucleotide.
3. The dsRNA of claim 2 , wherein said chemically modified nucleotide is a 2′-modified nucleotide.
4. The dsRNA of claim 3 , wherein said 2′-modified nucleotide is a 2′-methyl substituted nucleotide.
5. The dsRNA of claim 3 , wherein said 2′-modified nucleotide is a 2′-amino substituted nucleotide.
6. The dsRNA of claim 2 , wherein said chemically modified nucleotide is a locked nucleotide.
7. A vector encoding the dsRNA of claim 1 , wherein said vector is either a plasmid vector or a viral vector.
8. A cell transformed with the vector of claim 7 .
9. The dsRNA of claim 1 , wherein said dsRNA is modified so as to be resistant to RNA degradation.
10. The dsRNA of claim 2 , wherein only one nucleotide of at least one of said oligoribonucleotide strands is a chemically modified nucleotide.
11. The dsRNA of claim 1 , wherein said dsRNA is capable of specifically inhibiting the expression of said mammalian target gene using dsRNA-mediated interference.
12. The dsRNA of claim 1 , wherein said separate oligoribonucleotide strands are chemically linked with a linker comprising a covalent linker.
13. The dsRNA of claim 12 , wherein said covalent linker is a C18 linker.
14. The dsRNA of claim 1 , wherein said separate oligoribonucleotide strands are chemically linked with a linker comprising a labile linker.
15. The dsRNA of claim 14 , wherein said labile linker is a disulfide bridge.
16. The dsRNA of claim 1 , wherein said two separate complementary strands are fully complementary to each other.